NASDAQ:INBS Intelligent Bio Solutions (INBS) Stock Price, News & Analysis $1.29 +0.04 (+2.79%) Closing price 05/22/2025 03:49 PM EasternExtended Trading$1.38 +0.09 (+6.98%) As of 05:10 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Intelligent Bio Solutions Stock (NASDAQ:INBS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get INBS alerts:Sign Up Key Stats Today's Range$1.25▼$1.3150-Day Range$1.15▼$2.1752-Week Range$1.00▼$3.00Volume78,928 shsAverage Volume549,063 shsMarket Capitalization$8.91 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewIntelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.Read More… Intelligent Bio Solutions Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks14th Percentile Overall ScoreINBS MarketRank™: Intelligent Bio Solutions scored higher than 14% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Intelligent Bio Solutions. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Intelligent Bio Solutions are expected to grow in the coming year, from ($1.25) to $0.35 per share.Price to Book Value per Share RatioIntelligent Bio Solutions has a P/B Ratio of 1.61. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted7.95% of the float of Intelligent Bio Solutions has been sold short.Short Interest Ratio / Days to CoverIntelligent Bio Solutions has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Intelligent Bio Solutions has recently decreased by 1.44%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIntelligent Bio Solutions does not currently pay a dividend.Dividend GrowthIntelligent Bio Solutions does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted7.95% of the float of Intelligent Bio Solutions has been sold short.Short Interest Ratio / Days to CoverIntelligent Bio Solutions has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Intelligent Bio Solutions has recently decreased by 1.44%, indicating that investor sentiment is improving. News and Social Media3.3 / 5News Sentiment0.99 News SentimentIntelligent Bio Solutions has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Intelligent Bio Solutions this week, compared to 2 articles on an average week.Search Interest2 people have searched for INBS on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Intelligent Bio Solutions insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.28% of the stock of Intelligent Bio Solutions is held by insiders.Percentage Held by InstitutionsOnly 32.97% of the stock of Intelligent Bio Solutions is held by institutions.Read more about Intelligent Bio Solutions' insider trading history. Receive INBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter. Email Address INBS Stock News HeadlinesIntelligent Bio Solutions Inc. to Showcase Drug Testing Innovation at RISE25 Conference with Partner SMARTOXMay 22 at 9:12 AM | quiverquant.comIntelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug TestingMay 22 at 8:30 AM | globenewswire.comSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.May 23, 2025 | Stansberry Research (Ad)Intelligent Bio Solutions Inc. Successfully Conducts High-Volume Workforce Drug Testing for Barcaldine Regional Council in Queensland, AustraliaMay 19, 2025 | quiverquant.comIntelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce DeploymentMay 19, 2025 | globenewswire.comIBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Surpasses 450 Accounts as Fingerprint Drug Testing Expands GloballyMay 15, 2025 | finance.yahoo.comIntelligent Bio Solutions Inc. Reports 20% Quarterly Revenue Growth and 91% Year-over-Year Gross Profit Increase in Q3 2025May 15, 2025 | nasdaq.comIntelligent Bio Solutions Inc. Reports Significant Growth Across Global Operations with Over 450 Active Accounts and Expansion into New SectorsMay 15, 2025 | quiverquant.comSee More Headlines INBS Stock Analysis - Frequently Asked Questions How have INBS shares performed this year? Intelligent Bio Solutions' stock was trading at $1.40 at the start of the year. Since then, INBS stock has decreased by 7.9% and is now trading at $1.29. View the best growth stocks for 2025 here. How were Intelligent Bio Solutions' earnings last quarter? Intelligent Bio Solutions Inc. (NASDAQ:INBS) issued its earnings results on Thursday, February, 13th. The company reported ($0.50) earnings per share for the quarter. The company earned $610 billion during the quarter. Intelligent Bio Solutions had a negative trailing twelve-month return on equity of 146.03% and a negative net margin of 323.79%. When did Intelligent Bio Solutions' stock split? Intelligent Bio Solutions shares reverse split on Monday, January 29th 2024. The 1-12 reverse split was announced on Monday, January 29th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. Who are Intelligent Bio Solutions' major shareholders? Intelligent Bio Solutions' top institutional shareholders include Alyeska Investment Group L.P. (8.88%) and Altium Capital Management LLC (2.19%). View institutional ownership trends. How do I buy shares of Intelligent Bio Solutions? Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Intelligent Bio Solutions own? Based on aggregate information from My MarketBeat watchlists, some other companies that Intelligent Bio Solutions investors own include SoFi Technologies (SOFI), Plug Power (PLUG), Allarity Therapeutics (ALLR), Adial Pharmaceuticals (ADIL), AMC Entertainment (AMC), ARMOUR Residential REIT (ARR) and BIOLASE (BIOL). Company Calendar Last Earnings2/13/2025Today5/23/2025Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:INBS CIK1725430 Webgbs.inc Phone646-828-8258FaxN/AEmployees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,160,000.00 Net Margins-323.79% Pretax Margin-324.91% Return on Equity-146.03% Return on Assets-83.62% Debt Debt-to-Equity RatioN/A Current Ratio0.92 Quick Ratio0.76 Sales & Book Value Annual Sales$2.94 million Price / Sales3.04 Cash FlowN/A Price / Cash FlowN/A Book Value$0.80 per share Price / Book1.61Miscellaneous Outstanding Shares6,910,000Free Float5,264,000Market Cap$8.91 million OptionableNot Optionable Beta4.63 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (NASDAQ:INBS) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intelligent Bio Solutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intelligent Bio Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.